Literature DB >> 22864686

The soybean peptide lunasin promotes apoptosis of mammary epithelial cells via induction of tumor suppressor PTEN: similarities and distinct actions from soy isoflavone genistein.

John Mark P Pabona1, Bhuvanesh Dave, Ying Su, Maria Theresa E Montales, Ben O de Lumen, Elvira G de Mejia, Omar M Rahal, Rosalia C M Simmen.   

Abstract

Breast cancer is the leading cause of cancer deaths in women. Diet and lifestyle are major contributing factors to increased breast cancer risk. While mechanisms underlying dietary protection of mammary tumor formation are increasingly elucidated, there remains a dearth of knowledge on the nature and precise actions of specific bioactive components present in foods with purported health effects. The 43-amino acid peptide lunasin (LUN) is found in soybeans, is bioavailable similar to the isoflavone genistein (GEN), and thus may mediate the beneficial effects of soy food consumption. Here, we evaluated whether LUN displays common and distinct actions from those of GEN in non-malignant (mouse HC11) and malignant (human MCF-7) mammary epithelial cells. In MCF-7 cells, LUN up-regulated tumor suppressor phosphatase and tensin homolog deleted in chromosome ten (PTEN) promoter activity, increased PTEN transcript and protein levels and enhanced nuclear PTEN localization, similar to that shown for GEN in mammary epithelial cells. LUN-induced cellular apoptosis, akin to GEN, was mediated by PTEN, but unlike that for GEN, was p53-independent. LUN promoted E-cadherin and β-catenin non-nuclear localization similar to GEN, but unlike GEN, did not influence the proliferative effects of oncogene Wnt1 on HC11 cells. Further, LUN did not recapitulate GEN inhibitory effects on expansion of the cancer stem-like/progenitor population in MCF-7 cells. Results suggest the concerted actions of GEN and LUN on cellular apoptosis for potential mammary tumor preventive effects and highlight whole food consumption rather than intake of specific dietary supplements with limited biological effects for greater health benefits.

Entities:  

Year:  2012        PMID: 22864686      PMCID: PMC3535001          DOI: 10.1007/s12263-012-0307-5

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  51 in total

1.  PCAF modulates PTEN activity.

Authors:  Koichi Okumura; Michelle Mendoza; Robert M Bachoo; Ronald A DePinho; Webster K Cavenee; Frank B Furnari
Journal:  J Biol Chem       Date:  2006-07-07       Impact factor: 5.157

2.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet.

Authors:  P G Reeves; F H Nielsen; G C Fahey
Journal:  J Nutr       Date:  1993-11       Impact factor: 4.798

3.  The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN.

Authors:  Bhuvanesh Dave; Renea R Eason; S Renée Till; Yan Geng; Michael C Velarde; Thomas M Badger; Rosalia C M Simmen
Journal:  Carcinogenesis       Date:  2005-05-19       Impact factor: 4.944

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

5.  Inhibition of NMU-induced mammary tumorigenesis by dietary soy.

Authors:  Rosalia C M Simmen; Renea R Eason; S Reneé Till; Leon Chatman; Michael C Velarde; Yan Geng; Sohelia Korourian; Thomas M Badger
Journal:  Cancer Lett       Date:  2004-12-13       Impact factor: 8.679

6.  Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein.

Authors:  Aslamuzzaman Kazi; Kenyon G Daniel; David M Smith; Nagi B Kumar; Q Ping Dou
Journal:  Biochem Pharmacol       Date:  2003-09-15       Impact factor: 5.858

7.  E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.

Authors:  S Orsulic; O Huber; H Aberle; S Arnold; R Kemler
Journal:  J Cell Sci       Date:  1999-04       Impact factor: 5.285

8.  A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells.

Authors:  A F Galvez; B O de Lumen
Journal:  Nat Biotechnol       Date:  1999-05       Impact factor: 54.908

9.  Inhibition of core histone acetylation by the cancer preventive peptide lunasin.

Authors:  Hyung Jin Jeong; Jin Boo Jeong; Dae Seop Kim; Ben O de Lumen
Journal:  J Agric Food Chem       Date:  2007-02-07       Impact factor: 5.279

10.  Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products.

Authors:  Elvira Gonzalez de Mejia; Miguel Vásconez; Ben O de Lumen; Randall Nelson
Journal:  J Agric Food Chem       Date:  2004-09-22       Impact factor: 5.279

View more
  11 in total

1.  Ursolic acid activates the apoptosis of prostate cancer via ROCK/PTEN mediated mitochondrial translocation of cofilin-1.

Authors:  Dawei Mu; Gaobiao Zhou; Jianye Li; Bin Su; Heqing Guo
Journal:  Oncol Lett       Date:  2017-12-27       Impact factor: 2.967

2.  Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells.

Authors:  Maria Theresa E Montales; Rosalia C M Simmen; Ederlan S Ferreira; Valdir A Neves; Frank A Simmen
Journal:  Genes Nutr       Date:  2015-10-28       Impact factor: 5.523

3.  The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.

Authors:  Elizabeth J McConnell; Bharat Devapatla; Kavitha Yaddanapudi; Keith R Davis
Journal:  Oncotarget       Date:  2015-03-10

4.  Lunasin sensitivity in non-small cell lung cancer cells is linked to suppression of integrin signaling and changes in histone acetylation.

Authors:  Junichi Inaba; Elizabeth J McConnell; Keith R Davis
Journal:  Int J Mol Sci       Date:  2014-12-18       Impact factor: 5.923

5.  Potential Health Benefits Associated with Lunasin Concentration in Dietary Supplements and Lunasin-Enriched Soy Extract.

Authors:  Elvira Gonzalez de Mejia; Erick Damian Castañeda-Reyes; Luis Mojica; Vermont Dia; Hui Wang; Toni Wang; Lawrence A Johnson
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

6.  Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.

Authors:  Chris Shidal; Numan Al-Rayyan; Kavitha Yaddanapudi; Keith R Davis
Journal:  Oncotarget       Date:  2016-12-20

Review 7.  Reactive Oxygen Species, Superoxide Dimutases, and PTEN-p53-AKT-MDM2 Signaling Loop Network in Mesenchymal Stem/Stromal Cells Regulation.

Authors:  Satoru Matsuda; Yukie Nakagawa; Yasuko Kitagishi; Atsuko Nakanishi; Toshiyuki Murai
Journal:  Cells       Date:  2018-05-01       Impact factor: 6.600

8.  Exploratory analysis of the human breast DNA methylation profile upon soymilk exposure.

Authors:  Louis Coussement; Selin Bolca; Wim Van Criekinge; Geert Trooskens; Klaas Mensaert; Katrien Poels; Nathalie Roche; Phillip Blondeel; Lode Godderis; Herman Depypere; Tim De Meyer
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

Review 9.  Soybean Bioactive Peptides and Their Functional Properties.

Authors:  Cynthia Chatterjee; Stephen Gleddie; Chao-Wu Xiao
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

10.  Inhibitory Effects of Peptide Lunasin in Colorectal Cancer HCT-116 Cells and Their Tumorsphere-Derived Subpopulation.

Authors:  Samuel Fernández-Tomé; Fei Xu; Yanhui Han; Blanca Hernández-Ledesma; Hang Xiao
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.